Safeplus International Holdings Ltd. (ACAI)

[krays]

I agree, and speaking of patents, the patent I just posted about relates to the CSS device itself and addresses acute care for an arrested heart. Another patent application that I posted about recently (currently under review by USPTO) relates to therapeutic care for an enlarged heart. My thoughts are that the second application may provide a quicker strategy to bring this device to market as it may be much easier to initiate clinical trials and obtain consent from a living patient with an enlarged heart vs. a basically dead patient in cardiac arrest.

I would vote my significant number of shares in favor of the increase but apparently they are not eligible.
Regards,